References

  1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016 Sep 10;388(10049):1081-1088. PubMed | Google Scholar

  2. Bengsch B, Chang KM. Evolution in our understanding of hepatitis B virus virology and immunology. Clin Liver Dis. 2016 Nov;20(4):629-644. PubMed | Google Scholar

  3. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015:166. Google Scholar

  4. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005; 34 (6):1329-1339. PubMed | Google Scholar

  5. Borchardt SM, Kocharian A, Hopfensperger D, Davis JP. Prevention of perinatal transmission of hepatitis B virus: assessment among Wisconsin Maternity Hospitals. WMJ Off Publ State Med Soc Wis. 2016; 115(2):74-79. PubMed | Google Scholar

  6. Han GR, Xu CL, Zhao W, Yang YF. Management of chronic hepatitis B in pregnancy. World J Gastroenterol. 2012;18(33):4517-4521. PubMed | Google Scholar

  7. Pande C, Sarin S K, Patra S, Kumar A, Mishra S, Srivastava S et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat. 2013;20(11):801-810. Google Scholar

  8. Li Z, Hou X, Cao G. Is mother-to-infant transmission the most important factor for persistent HBV infection?. Emerg Microb Infect. 2015;4(5):e30. PubMed | Google Scholar

  9. Cheung KW, Seto MTY, Wong SF. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2013;169(1):17-23. PubMed | Google Scholar

  10. Kim HY, Choi JY, Park CH, Jang JW, Kim CW, Bae SH et al. Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus. J Clin Virol. 2013;56(4):299-305. PubMed | Google Scholar

  11. Konaté Anselme. Epidémiologie de l'infection par le virus de l'hépatite B en Afrique. Développement et santé. 2012;200:11-17.

  12. Laku Stephen Kirbak A, Nganga Z, Omolo J, Idris H, Usman A, Baguma Mbabazi W. Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan. Pan Afr Med J. 2017; 26:72. Google Scholar

  13. Bigot KA, Kodjoh N, Zohoun IS, Hountondji A, Latoundji S, Takpara L et al. Séroprévalence de l'antigène HBs du virus de l'hépatite B chez les femmes enceintes et leurs enfants. Med Afr Noire. 1992;39(7):487-90.

  14. Kodjoh N. Situation de la lutte contre les hépatites B et C en Afrique. Med Trop. 2015;22:141-144. PubMed | Google Scholar

  15. Candotti D, Danso K, Allain JP. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa.J Gen Virol. 2007 Oct;88(Pt 10):2686-95. PubMed | Google Scholar

  16. Sangaré L, Sombié R, Combasséré AW, Kouanda A, Kania D, Zerbo O et al. Transmission anténatale du virus de l'hépatite B en zone de prévalence modérée du VIH, Ouagadougou, Burkina Faso. Bull Soc Pathol Ex. 2009; 102(4):226-229. PubMed | Google Scholar

  17. Sidibe S, Youssoufi Sacko B, Traoré I. Prévalence des marqueurs sérologiques du virus de l'hépatite B chez les femmes enceintes dans le district de Bamako, Mali. Bull Soc Pathol Ex. 2001;94(4):339-341. PubMed | Google Scholar

  18. Mamadou S, Ide M, Maazou ARA, Aoula B, Labo S, Bozari M. HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa.HIV AIDS (Auckl). 2012;4:1-4. PubMed | Google Scholar

  19. Hannachi N, Bahri O, Mhalla S, Marzouk M, Sadraoui A, Belguith A et al. Hépatite virale B chez les femmes enceintes tunisiennes: facteurs de risque et intérêt de l'étude de la réplication virale en cas d'antigène HBe négatif. Pathol Biol. 2009;57(3):43-47. Google Scholar

  20. Çevik E, Inan N, Baki Çentürk M, Demirel A, Kumbasar H, ArÜsoy A et al. Seroprevalance of Hepatitis B among Pregnant Women and Neonates Born to HBsAg Positive Mothers in Batman. Viral Hepatitis J. 2014;20(3):115-119. Google Scholar

  21. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA et al. comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. PubMed

  22. US Centers for Disease Control (CDC). Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep. 1988; 37:341-346. Google Scholar

  23. Organisation Mondiale de la Santé. Vaccins anti-hépatite B. Relevé épidémiologique hebdomadaire. 2017;92:369-392. PubMed

  24. Angounda BM, Bokilo A, Boumba LMA, Itoua C, Ahombo G, Moukassa D et al. Prevalence of serologic markers and risk factors for Hepatitis B virus among pregnant women in Brazzaville, Congo. International Journal of Science and Research(IJSR).2016;5(1):1907-1912.

  25. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterol. 2006;131:283-311. PubMed | Google Scholar

  26. Bani I, Mahfouz MS, Maki E, Gaffar A, Elhassan I, Yassin AO et al. Prevalence and risk factors of Hepatitis B Virus among pregnant women in Jazan Region-Kingdom of Saudi Arabia. J Biol Agr Healthcare. 2012;2(7):39-43. Google Scholar